Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Pharmacy Residency Programs

PGY2 Oncology Pharmacy Residency

Program Description

The Postgraduate Year Two Oncology Pharmacy Residency at Seattle Children’s is a 52-week ASHP accredited training program that provides training in the field of oncology with a focus on pediatrics. Experience is gained in general hematology/oncology, stem cell transplantation and ambulatory care.  Opportunities to explore additional areas of interest are available through electives both on and off site.  Our comprehensive, multidisciplinary team of pediatric cancer experts treats more than 250 newly diagnosed patients with cancer every year and provides follow-up care to more than 12,700 children and adolescents.    

Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic or other specialized positions, along with board certification, if available.

Practice Areas and Requirements

  1. Required experiences:
    • Orientation (4 weeks)
    • Inpatient Oncology Solid Tumor I (3 weeks)
    • Inpatient Oncology Solid Tumor II (3 weeks)
    • Inpatient Oncology Liquid Tumor I (3 weeks)
    • Inpatient Oncology Liquid Tumor II (3 weeks)
    • Outpatient Oncology (3-4 weeks)
    • Inpatient Bone Marrow Transplant I (3 weeks)
    • Inpatient Bone Marrow Transplant II (3 weeks)
    • Outpatient Bone Marrow Transplant (3-4 weeks)
    • Investigational Drugs Service (3 weeks)
  2. Elective experiences from Adult Oncology clinics at Fred Hutch Cancer Center:
    • (Electives may consist of any of the following to make up two 2-week blocks)
    • Breast Cancer
    • Lung Cancer
    • Thoracic/head/neck
    • Hematology (leukemia, lymphoma, multiple myeloma)
    • Gastrointestinal
    • Genitourinary
    • Melanoma/renal cell
    • Sarcomas
  3. Longitudinal experiences:
    • Drug distribution staffing in the main central pharmacy and HEM/ONC/BMT clinical staffing on weekends
    • Every 3rd weekend plus three hours per week PM shift and an additional three hour PM shift every 4th week
    • Complete a clinical research project, present a poster at a conference, and submit a final research manuscript
    • Present one pharmacist continuing education topic on oncology/BMT
    • Complete at least two drug information projects for P&T Committee (e.g., monographs, MUE, class review)
    • Complete two drug information projects for the oncology department (e.g., drug information question, policy update, guideline of care review, etc).
  4. ACHR for at least 90% of evaluated objectives in PharmAcademic
  5. Completion of 100% of required specialty disease topics in Appendix A   

Qualifications of the Applicant

Selected applicants will be invited for a virtual interview with Seattle Children’s in January or February. The applicant must meet the following general requirements:

  • Applicants must be graduates of an Accreditation Council for Pharmacy Education (ACPE)-accredited degree program (or one in process of pursuing accreditation) or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP).
  • Successful completion of an ASHP-accredited PGY1 residency
  • PPS Midyear interview or similar meeting from Seattle Children’s Hospital RPD (please contact RPD if unable to make PPS)  
  • Licensed or eligible for licensure in the State of Washington
  • Participate in the ASHP Pharmacy Resident Matching Program. Program code number: 744660.

Application Materials

Submitted through PhORCAS.

  • Personal statement outlining career goals, areas of interest and reasons for applying to the residency program at Seattle Children’s
  • Curriculum vitae
  • Three professional letters of recommendation
    • At least two letters must be written by preceptors.

Address inquiries to:

Evan Abrass, PharmD, BCOP
PGY2 Oncology Pharmacy Residency Program Director
Seattle Children's
M/S MB.5.420
4800 Sand Point Way NE
Seattle, WA 98105

This residency site agrees that no person at this site will solicit, accept or use any ranking-related information from any residency applicant.

Current Resident

Leah Nelson, PharmD
School: University of Kansas School of Pharmacy, Wichita, Kansas
PGY1 Program: Wesley Medical Center, Wichita, Kansas